These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33846030)

  • 1. The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in taste dysgeusia in COVID-19 patients.
    Singh CV; Jain S; Parveen S; Deshmukh P
    Am J Otolaryngol; 2021; 42(4):103009. PubMed ID: 33846030
    [No Abstract]   [Full Text] [Related]  

  • 2. The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients.
    Singh CV; Jain S; Parveen S
    Am J Otolaryngol; 2021; 42(3):102892. PubMed ID: 33493729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter to the editor regarding "The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients".
    Verma RR; Gupta N; Singh M
    Am J Otolaryngol; 2021; 42(5):103103. PubMed ID: 34116850
    [No Abstract]   [Full Text] [Related]  

  • 4. The interest of fluticasone nasal spray in COVID-19 related anosmia is still not demonstrated.
    Lechien JR; Hoch CC; Vaira LA; Saussez S
    Am J Otolaryngol; 2021; 42(4):103008. PubMed ID: 33810883
    [No Abstract]   [Full Text] [Related]  

  • 5. Anosmia (smell failure) and dysgeusia (taste distortion) in COVID-19: it is genetic.
    Hendaus MA
    J Biomol Struct Dyn; 2023 Apr; 41(7):3162-3165. PubMed ID: 35147485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should anosmia and dysgeusia be a concern for oral and maxillofacial surgeons during the COVID-19 pandemic?
    Alharbi H; You S; Katz J
    Oral Maxillofac Surg; 2022 Mar; 26(1):105-111. PubMed ID: 33954852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of any form of steroids in comparison with that of other medications on the duration of olfactory dysfunction in patients with COVID-19: A systematic review of randomized trials and quasi-experimental studies.
    Winn PZ; Hlaing T; Tun KM; Lei SL
    PLoS One; 2023; 18(8):e0288285. PubMed ID: 37531338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic.
    Krishnakumar HN; Momtaz DA; Sherwani A; Mhapankar A; Gonuguntla RK; Maleki A; Abbas A; Ghali AN; Al Afif A
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):505-509. PubMed ID: 36209486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 with and without anosmia or dysgeusia: A case-control study.
    Dev N; Sankar J; Gupta N; Meena RC; Singh C; Gupta DK; Sen MK
    J Med Virol; 2021 Apr; 93(4):2499-2504. PubMed ID: 33417259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France.
    Klopfenstein T; Zahra H; Kadiane-Oussou NJ; Lepiller Q; Royer PY; Toko L; Gendrin V; Zayet S
    Int J Infect Dis; 2020 Nov; 100():117-122. PubMed ID: 32771635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced olfactory and gustatory dysfunction: Analysis of FDA adverse events reporting system.
    Debbaneh P; McKinnon L; Haidari M; Liang J
    Auris Nasus Larynx; 2023 Aug; 50(4):558-564. PubMed ID: 36682949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of pentasodium diethylenetriamine pentaacetate in ameliorating anosmia post COVID-19.
    Imam MS; Abdelazim MH; Abdelazim AH; Ismaiel WF; Gamal M; Abourehab MAS; Alghamdi S; Alghamdi MA; Ghoneim MM; Elwany S
    Am J Otolaryngol; 2023; 44(4):103871. PubMed ID: 37018923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can symptoms of anosmia and dysgeusia be diagnostic for COVID-19?
    Zahra SA; Iddawela S; Pillai K; Choudhury RY; Harky A
    Brain Behav; 2020 Nov; 10(11):e01839. PubMed ID: 32935915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluticasone propionate suppresses the SARS-CoV-2 induced increase in respiratory epithelial permeability in vitro.
    Martens K; Vanhulle E; Viskens AS; Hellings PW; Vermeire K
    Rhinology; 2023 Apr; 61(2):161-169. PubMed ID: 36479866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does COVID-19 cause permanent damage to olfactory and gustatory function?
    Paolo G
    Med Hypotheses; 2020 Oct; 143():110086. PubMed ID: 32721795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of smell and taste in COVID-19 infection in adolescents.
    Kumar L; Kahlon N; Jain A; Kaur J; Singh M; Pandey AK
    Int J Pediatr Otorhinolaryngol; 2021 Mar; 142():110626. PubMed ID: 33477014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis.
    Mutiawati E; Fahriani M; Mamada SS; Fajar JK; Frediansyah A; Maliga HA; Ilmawan M; Emran TB; Ophinni Y; Ichsan I; Musadir N; Rabaan AA; Dhama K; Syahrul S; Nainu F; Harapan H
    F1000Res; 2021; 10():40. PubMed ID: 33824716
    [No Abstract]   [Full Text] [Related]  

  • 18. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial.
    Abdelalim AA; Mohamady AA; Elsayed RA; Elawady MA; Ghallab AF
    Am J Otolaryngol; 2021; 42(2):102884. PubMed ID: 33429174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2.
    Meister TL; Todt D; Brüggemann Y; Steinmann J; Banava S; Brill FHH; Steinmann J; Pfaender S; Steinmann E
    J Hosp Infect; 2022 Feb; 120():9-13. PubMed ID: 34752803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anosmia: A Clinical Indicator of COVID-19 Reinfection.
    Jain A; Kaur J; Rai AK; Pandey AK
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):180S-181S. PubMed ID: 33295221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.